Haipeng Guo
- Molecular Biology
- Cardiology and Cardiovascular Medicine top 5%
- Pulmonary and Respiratory Medicine top 10%
- Physiology top 10%
- Epidemiology
- Topics
- Signaling Pathways in Disease (8 papers)Cardiac Fibrosis and Remodeling (7 papers)Pulmonary Hypertension Research and Treatments (5 papers)
- Partner nations
- ChinaUnited StatesThailand
In The Last Decade
Haipeng Guo
57 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 109
- Molecular Biology 551
- Cardiology and Cardiovascular Medicine 361
- Pulmonary and Respiratory Medicine 218
- Physiology 195
- Epidemiology 189
Countries citing papers authored by Haipeng Guo
This map shows the geographic impact of Haipeng Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haipeng Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haipeng Guo more than expected).
Fields of papers citing papers by Haipeng Guo
This network shows the impact of papers produced by Haipeng Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haipeng Guo. The network helps show where Haipeng Guo may publish in the future.
Co-authorship network of co-authors of Haipeng Guo
This figure shows the co-authorship network connecting the top 25 collaborators of Haipeng Guo. A scholar is included among the top collaborators of Haipeng Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haipeng Guo. Haipeng Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 4 | |
| 3 | 8 | |
| 4 | 22 | |
| 5 | 1 | |
| 6 | 2 | |
| 7 | 6 | |
| 8 | 6 | |
| 9 | 25 | |
| 10 | 10 | |
| 11 | 21 | |
| 12 | 22 | |
| 13 | 12 | |
| 14 | 18 | |
| 15 | 95 | |
| 16 | 23 | |
| 17 | 23 | |
| 18 | 66 | |
| 19 | 26 | |
| 20 | 30 |
About Haipeng Guo
Haipeng Guo is a scholar working on Applied Microbiology and Biotechnology, Biological Psychiatry and Cardiology and Cardiovascular Medicine, having authored 58 papers that have together received 1.4k indexed citations. Recurring topics across this work include Signaling Pathways in Disease (8 papers), Cardiac Fibrosis and Remodeling (7 papers) and Pulmonary Hypertension Research and Treatments (5 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (361 citations), Applied Microbiology and Biotechnology (19 citations) and Biochemistry (65 citations). Haipeng Guo has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Heng Zhou, Wei Deng, Qizhu Tang, Xin Xu, Zhongbing Lu, Yingjie Chen, Dawei Wu, Dachun Xu, Hao Wang and John Fassett. Their work appears in journals such as Nature Communications, PLoS ONE and Circulation Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.